Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype

被引：6

作者：

Grant, H. ^{[1
]}

Jiang, X. ^{[2
,3
]}

Stebbing, J. ^{[4
]}

Foroni, L. ^{[5
]}

Craddock, C. ^{[6
]}

Griffiths, M. ^{[7
]}

Clark, R. E. ^{[8
]}

O'Brien, S. ^{[9
]}

Khorashad, J. S. ^{[5
]}

Gerrard, G. ^{[5
]}

Wang, L. ^{[8
]}

Irving, J. A. E. ^{[9
]}

Wang, M. ^{[10
]}

Karran, L. ^{[11
]}

Dyer, M. J. S. ^{[11
]}

Forrest, D. ^{[12
]}

Page, K. ^{[1
]}

Eaves, C. J. ^{[2
,3
]}

Woolfson, A. ^{[13
]}

机构：

[1] UCL, Dept Math, London, England

[2] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada

[3] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada

[4] Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, Dept Med Oncol, London, England

[5] Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, Dept Med, London, England

[6] Queen Elizabeth Hosp, Ctr Clin Haematol, Birmingham B15 2TH, W Midlands, England

[7] Birmingham Womens NHS Fdn Trust, W Midlands Reg Genet Lab, Birmingham, W Midlands, England

[8] Univ Liverpool, Royal Liverpool Univ Hosp, Liverpool L69 3BX, Merseyside, England

[9] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[10] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 2QH, England

[11] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England

[12] British Columbia Canc Agcy, Div Hematol, Leukaemia BMT Program British Columbia, Vancouver, BC V5Z 4E6, Canada

[13] Bristol Myers Squibb Co, Discovery Med Oncol, Princeton, NJ USA

来源：

LEUKEMIA | 2010年 / 24卷 / 10期

基金：

英国医学研究理事会;

关键词：

RESISTANCE; MECHANISMS; INHIBITOR; IMATINIB;

D O I：

10.1038/leu.2010.179

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1817 / 1821

页数：5

共 50 条

[1] Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Soverini, Simona
de Benedittis, Caterina
Mancini, Manuela
Martinelli, Giovanni
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S120 - S128
[2] BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients
McCarron, Sarah L.
O'Connor, Lisa M.
Langabeer, Stephen E.
Conneally, Eibhlin
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (02) : 170 - 173
[3] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
Erbilgin, Yucel
Eskazan, Ahmet Emre
Ng, Ozden Hatirnaz
Salihoglu, Ayse
Elverdi, Tugrul
Firtina, Sinem
Tasar, Orcun
Mercan, Sevcan
Sisko, Sinem
Khodzhaev, Khusan
Ongoren, Seniz
Ar, Muhlis Cem
Baslar, Zafer
Soysal, Teoman
Sayitoglu, Muge
Ozbek, Ugur
LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
[4] Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia
Yoo, Hea-Lyun
Kim, Soo-Hyun
Choi, Soo-Young
Lee, Sung-Eun
Kim, Dong-Wook
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (07) : 406 - +
[5] Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
Haddad, Fadi
Kantarjian, Hagop
Issa, Ghayas C.
Jabbour, Elias
Sasaki, Koji
LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1714 - 1717
[6] Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study
Abu Seman, Zahidah
Ahid, Fadly
Kamaluddin, Nor Rizan
Sahid, Ermi Neiza Mohd
Esa, Ezalia
Said, Siti Shahrum Muhamed
Azman, Norazlina
Mat, Wan Khairull Dhalila Wan
Abdullah, Julia
Ali, Nurul Aqilah
Khalid, Mohd Khairul Nizam Mohd
Yusoff, Yuslina Mat
BMC RESEARCH NOTES, 2024, 17 (01)
[7] Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
Soverini, Simona
Branford, Susan
Nicolini, Franck E.
Talpaz, Moshe
Deininger, Michael W. N.
Martinelli, Giovanni
Mueller, Martin C.
Radich, Jerald P.
Shah, Neil P.
LEUKEMIA RESEARCH, 2014, 38 (01) : 10 - 20
[8] Mutations in the BCR-ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis
Liu, Jingjing
Yang, Haiping
Xu, Xiuwen
Yi, Shujuan
Meng, Li
ONCOLOGY LETTERS, 2020, 20 (02) : 1071 - 1076
[9] BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
Roy, Swagata
Jorgensen, Heather G.
Roy, Poornima
El Baky, Mohamed Abed
Melo, Junia V.
Strathdee, Gordon
Holyoake, Tessa L.
Bartholomew, Chris
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (04) : 446 - 456
[10] Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
Krumbholz, Manuela
Karl, Matthias
Tauer, Josephine T.
Thiede, Christian
Rascher, Wolfgang
Suttorp, Meinolf
Metzler, Markus
GENES CHROMOSOMES & CANCER, 2012, 51 (11) : 1045 - 1053

← 1 2 3 4 5 →